Serum musclin is not associated to insulin resistance in adults with and without metabolic syndrome

ABSTRACT: Myokines regulate metabolism in different tissues. Musclin is a myokine secreted by muscle fibers type II (FT-II). Since musclin induces insulin resistance (IR) in vitro, it could be associated to IR in patients within metabolic syndrome (MS). We aimed to evaluate the relationship between...

Full description

Autores:
Calderón Vélez, Juan Camilo
Sánchez López, Yeliana Lucía
Castro Valencia, Leonardo Andrés
Aristizábal Rivera, Juan Carlos
Estrada Castrillón, Mauricio
Narváez Sánchez, Raul
Gallo Villegas, Jaime Alberto
Tipo de recurso:
Article of journal
Fecha de publicación:
2017
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/43132
Acceso en línea:
https://hdl.handle.net/10495/43132
Palabra clave:
Resistencia a la Insulina
Insulin Resistance
Síndrome Metabólico
Metabolic Syndrome
https://id.nlm.nih.gov/mesh/D007333
https://id.nlm.nih.gov/mesh/D024821
Rights
openAccess
License
http://creativecommons.org/licenses/by-nc-nd/2.5/co/
Description
Summary:ABSTRACT: Myokines regulate metabolism in different tissues. Musclin is a myokine secreted by muscle fibers type II (FT-II). Since musclin induces insulin resistance (IR) in vitro, it could be associated to IR in patients within metabolic syndrome (MS). We aimed to evaluate the relationship between serum musclin, IR, muscle mass and area of FT-II in humans with and without MS. Patients with (n=23) and without (n=10) MS, comparable in age and sex were recruited. Medical and anthropometric assessments, biochemical tests, serum musclin measurements by ELISA, global and regional muscle mass determination by dual X-ray absorptiometry and area of FT-II in right vastus lateralis muscle estimation by proton magnetic resonance spectroscopy were performed in all patients. Muscle mass indexes for global and right thigh muscle mass (Kg muscle mass/m2, Kg muscle mass/Kg body mass, Kg muscle mass/Kg fat mass) were also calculated. Homeostatic model assessment as an indicator of IR was calculated as: HOMA-IR=((glycemia (mg/dl)/18)*insulin(μU/ml))/22.5. Patients with MS had more IR than control subjects (HOMA-IR 4.6±2.2 vs. 1.6±0.6; mean±standard error; P<0.05). There were no differences in circulating musclin or in absolute muscle values or muscle mass indexes between groups. Positive correlations between IR and both total and thigh fat mass (r>0.46; P<0.05) were obtained. Also, positive correlations were found between musclin and total and thigh muscle mass (r>0.51; P<0.05). Area of FT-II was positively associated to muscle mass indexes (r>0.49; P<0.05). We found an inverse tendency between IR and muscle mass (r -0.34; P=0.07), but we did not observe a correlation between IR and musclin. In conclusion, muscle mass was associated to the concentration of circulating musclin, however musclin was not associated to the degree of IR in patients with and without MS. These findings conflict some previously reported in other experimental models.